L&G FTSE 100 Super Short Strategy (Daily 2x) UCITS ETF

The Fund is a passively managed exchange traded Fund that aims to track the performance of the FTSE 100 Daily Super Short Strategy Index (the " Index "), subject to the deduction of the ongoing charges and other costs associated with operating the Fund. Shares in this Share Class (the " Shares ") are denominated in GBP and can be bought and sold on stock exchanges by ordinary investors using an intermediary (e.g. a stockbroker). In normal circumstances, only Authorised Participants may buy and sell Shares directly with the Company. Authorised Participants may redeem their Shares on demand in accordance with the "Dealing Timetable" published on http://www.lgim.com . The index is a leveraged inverse index. The daily percentage change in the level of the Index is intended to reflect twice the daily percentage change in the level of the FTSE 100 Total Return Declared Dividend Index (the "Underlying Index") on an inverse basis plus an implied amount reflecting the interest accruing on the cash proceeds earned from the sale of the Underlying Index portfolio (the "Interest Rate") less an implied amount reflecting the cost of borrowing the Underlying Index portfolio so as to create the leveraged exposure (the "Borrowing Cost"). The Underlying Index is comprised of the 100 largest companies (determined by reference to the total market value of a company's shares) which are publically traded in the UK. Each company is weighted according to the total market value of the proportion of its shares that are freely tradable by the public (i.e. not subject to any restrictions or fixed ownership). In tracking the Index, the Fund is exposed on each day to an inverse multiple (by a factor of 2) of that day's movement in the value of the Underlying Index as adjusted to reflect the Interest Rate and Borrowing Cost built into the Index and charges and expenses applied to the Fund. As the Index rebalances daily, the Fund may not be a suitable investment for periods of longer than one da

Synthetic replication - unfunded swap backed by collateral

PIR compliant

No

PEA compliant

No

PEA-PME compliant

No